China NMPA Drug Inspection - Jiangxi Pengshi Guoyaotang Pharmaceutical Co., Ltd. - Lotus root
China NMPA drug inspection for Jiangxi Pengshi Guoyaotang Pharmaceutical Co., Ltd. published October 22, 2020. Drug: Lotus root. The Chongqing Municipal Drug Administration issued its first Drug Quality Bulletin for 2018, detailing non-compliance di
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jiangxi Pengshi Guoyaotang Pharmaceutical Co., Ltd. published October 22, 2020. Drug: Lotus root. The Chongqing Municipal Drug Administration issued its first Drug Quality Bulletin for 2018, detailing non-compliance di
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox